Rena Morita

1.3k total citations
36 papers, 943 citations indexed

About

Rena Morita is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Rena Morita has authored 36 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 12 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Rena Morita's work include Cancer Cells and Metastasis (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immunotherapy and Immune Responses (8 papers). Rena Morita is often cited by papers focused on Cancer Cells and Metastasis (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immunotherapy and Immune Responses (8 papers). Rena Morita collaborates with scholars based in Japan, United States and Netherlands. Rena Morita's co-authors include Toshihiko Torigoe, Yoshihiko Hirohashi, Noriyuki Sato, Akari Takahashi, Yasuaki Tamura, Hiroko Asanuma, Tôru Kondo, Tadashi Hasegawa, Satoko Inoda and Takayuki Kanaseki and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Rena Morita

35 papers receiving 934 citations

Peers

Rena Morita
Iva Truxová Czechia
Alex W. Tong United States
Daniel R. Vlock United States
Beena O. Pappen United States
Walter Hanel United States
Chelsea Bolyard United States
Rena Morita
Citations per year, relative to Rena Morita Rena Morita (= 1×) peers Hiep Phuc Dong

Countries citing papers authored by Rena Morita

Since Specialization
Citations

This map shows the geographic impact of Rena Morita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rena Morita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rena Morita more than expected).

Fields of papers citing papers by Rena Morita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rena Morita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rena Morita. The network helps show where Rena Morita may publish in the future.

Co-authorship network of co-authors of Rena Morita

This figure shows the co-authorship network connecting the top 25 collaborators of Rena Morita. A scholar is included among the top collaborators of Rena Morita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rena Morita. Rena Morita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murai, Aiko, Yuka Mizue, Terufumi Kubo, et al.. (2024). Restoration of ARID1A Protein in ARID1A-deficient Clear Cell Carcinoma of the Ovary Attenuates Reactivity to Cytotoxic T Lymphocytes. Cancer Genomics & Proteomics. 21(4). 414–420. 1 indexed citations
2.
Kawai, Noriko, Yuma Ebihara, Aiko Murai, et al.. (2024). Aldehyde Dehydrogenese-1 High Cancer Stem-like Cells/Cancer-initiating Cells Escape from Cytotoxic T Lymphocytes due to Lower Expression of Human Leukocyte Antigen Class 1. Anticancer Research. 44(5). 1877–1883. 3 indexed citations
3.
Hirohashi, Yoshihiko, Rena Morita, Akihiro Miyazaki, et al.. (2023). Exploring olfactory receptor family 7 subfamily C member 1 as a novel oral cancer stem cell target for immunotherapy. Cancer Science. 114(9). 3496–3508. 4 indexed citations
4.
Morita, Rena & Kiyoshi Kasai. (2022). Lymphomatoid papulosis during immune checkpoint inhibitor treatment. International Journal of Hematology. 116(2). 155–157. 2 indexed citations
5.
Kubo, Terufumi, Yoshihiko Hirohashi, Tomohide Tsukahara, et al.. (2021). Immunopathological basis of immune-related adverse events induced by immune checkpoint blockade therapy. Immunological Medicine. 45(2). 108–118. 14 indexed citations
6.
Nakatsugawa, Munehide, Jun’ichi Kobayashi, Rena Morita, et al.. (2020). Borderline Microenvironment Fibrosis Is a Novel Poor Prognostic Marker of Oral Squamous Cell Carcinoma. Anticancer Research. 40(8). 4319–4326. 5 indexed citations
7.
Mariya, Tasuku, Terufumi Kubo, Yoshihiko Hirohashi, et al.. (2020). Less correlation between mismatch repair proteins deficiency and decreased expression of HLA class I molecules in endometrial carcinoma: a different propensity from colorectal cancer. Medical Molecular Morphology. 54(1). 14–22. 3 indexed citations
8.
Hirohashi, Yoshihiko, Aiko Murai, Rena Morita, et al.. (2016). Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480. PLoS ONE. 11(7). e0158903–e0158903. 9 indexed citations
9.
Morita, Rena, Yoshihiko Hirohashi, Munehide Nakatsugawa, et al.. (2014). Production of Multiple CTL Epitopes from Multiple Tumor-Associated Antigens. Methods in molecular biology. 1139. 345–355. 8 indexed citations
10.
Hashino, Satoshi, Rena Morita, Masahiro Onozawa, et al.. (2013). Fungemia due to Trichosporon dermatis in a patient with refractory Burkitt's leukemia. Blood Research. 48(2). 154–154. 10 indexed citations
11.
Kuroda, Takafumi, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.. (2013). ALDH1-High Ovarian Cancer Stem-Like Cells Can Be Isolated from Serous and Clear Cell Adenocarcinoma Cells, and ALDH1 High Expression Is Associated with Poor Prognosis. PLoS ONE. 8(6). e65158–e65158. 89 indexed citations
12.
Yasuda, Kazuyo, Toshihiko Torigoe, Rena Morita, et al.. (2013). Ovarian Cancer Stem Cells Are Enriched in Side Population and Aldehyde Dehydrogenase Bright Overlapping Population. PLoS ONE. 8(8). e68187–e68187. 59 indexed citations
13.
Nishizawa, Satoshi, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.. (2012). HSP DNAJB8 Controls Tumor-Initiating Ability in Renal Cancer Stem–like Cells. Cancer Research. 72(11). 2844–2854. 101 indexed citations
14.
Hirohashi, Yoshihiko, Toshihiko Torigoe, Satoko Inoda, et al.. (2012). Cytotoxic T lymphocytes: Sniping cancer stem cells. OncoImmunology. 1(1). 123–125. 27 indexed citations
15.
Nakatsugawa, Munehide, Akari Takahashi, Yoshihiko Hirohashi, et al.. (2011). SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity. Laboratory Investigation. 91(12). 1796–1804. 109 indexed citations
16.
Inoda, Satoko, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.. (2011). Cytotoxic T Lymphocytes Efficiently Recognize Human Colon Cancer Stem-Like Cells. American Journal Of Pathology. 178(4). 1805–1813. 97 indexed citations
17.
Inoda, Satoko, Rena Morita, Yoshihiko Hirohashi, et al.. (2010). The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma. Experimental and Molecular Pathology. 90(1). 55–60. 39 indexed citations
18.
Shirai, Shinichi, Satoshi Hashino, Rena Morita, et al.. (2009). [Hypogammaglobulinemia with a clinical course similar to that of drug-induced hypersensitivity syndrome].. PubMed. 50(1). 23–8. 1 indexed citations
19.
Onozawa, Masahiro, Satoshi Hashino, Stephanie Darmanin, et al.. (2008). HB Vaccination in the Prevention of Viral Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients with Previous HBV Infection. Biology of Blood and Marrow Transplantation. 14(11). 1226–1230. 35 indexed citations
20.
Shiratori, Souichi, Atsushi Yasumoto, Junji Tanaka, et al.. (2008). A Retrospective Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Adult T Cell Leukemia/Lymphoma (ATL): Clinical Impact of Graft-versus-Leukemia/Lymphoma Effect. Biology of Blood and Marrow Transplantation. 14(7). 817–823. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026